NVAX Novavax, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 6, 2026
$10,46
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$6,20rendah 52m
$11,97tinggi 52m
Kapitalisasi Pasar (MRQ)
$1.72B
P/E (TTM)
-7.7
EPS (TTM)
$-1.35
Pendapatan (TTM)
$414M
lencana Anda
Rentang 52M
$6–$12
Peringkat Analis
BUY
Target Harga
$14
P/E
-7.7
ROE
323.7%
Margin Laba Bersih
-59.9%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
NVAX Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$10.46
Kapitalisasi Pasar (MRQ)
$1.72B
P/E (TTM)
-7.7
EPS (TTM)
$-1.35
Pendapatan (TTM)
$414M
ROE (TTM)
323.7%
Rentang 52M
$6–$12
NVAX Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 10 Mei 2019 | 1-for-20 | Terbalik |
Tentang Novavax, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
Novavax, Inc. adalah sebuah perusahaan pengembangan vaksin Amerika Serikat yang bermarkas besar di Gaithersburg, Maryland, dengan fasilitas-fasilitas tambahan di Rockville, Maryland dan Uppsala, Swedia. Pada 2020, perusahaan tersebut menjalani pengujian klinis Tahap III terhadap orang-orang dewasa untuk vaksin kandidatnya untuk flu musiman, NanoFlu dan vaksin kandidat untuk pencegahan COVID-19.
Referensi
Bacaan tambahan
"Novavax, Inc. Common Stock (NVAX) News Headlines". Market Activity. Nasdaq. Diakses tanggal 25 Jan 2020.{{cite web}}: Pemeliharaan CS1: Status URL (link) Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link) Continuously updated listing of Nasdaq publications related to Novavax, newest items first.
Pranala luar
Situs web resmi
Data bisnis Novavax, Inc.:
Sumber: Wikipedia, CC BY-SA 4.0 · Lihat di Wikipedia ↗
sektorHealthcare
industriBiotechnology
karyawan749
negaraUS
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$1.12B2016-12-31 → 2025-12-31
EPS$2.582019-12-31 → 2025-12-31
Arus Kas Bebas·2016-12-31 → 2021-12-31
Margin bersih-59.9%2016-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | NVAX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E (TTM) | -7.7rata-rata 5T ≈-2.4 | ≈-2.4 | · | · | |
| P/S (TTM) | 4.2rata-rata 5T ≈2.7 | ≈2.7 | 25.6 | Kurang nilai | |
| P/B (MRQ) | -9.0rata-rata 5T ≈-8.8 | ≈-8.8 | · | · | |
| Price / Cash Flow (Harga / Arus Kas) | -7.2rata-rata 5T ≈2.3 | ≈2.3 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | NVAX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Margin Operasi (TTM) | -56.6%rata-rata 5T ≈-46.7% | ≈-46.7% | -701.6% | Tingkat teratas | |
| EBITDA Margin (Margin EBITDA) | 42.8%rata-rata 5T ≈-43.4% | ≈-43.4% | -701.6% | Tingkat teratas | |
| Margin Sebelum Pajak (TTM) | -59.3%rata-rata 5T ≈-44.9% | ≈-44.9% | -660.8% | Tingkat teratas | |
| Margin Laba Bersih (TTM) | -59.9%rata-rata 5T ≈-45.8% | ≈-45.8% | -660.8% | Tingkat teratas | |
| ROA (TTM) | -21.6%rata-rata 5T ≈-23.4% | ≈-23.4% | -19.8% | Tingkat teratas | |
| ROE (TTM) | 323.7%rata-rata 5T ≈-787.4% | ≈-787.4% | -58.3% | Lemah | |
| ROIC | -352.9%rata-rata 5T ≈71.8% | ≈71.8% | -62.3% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | NVAX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 2.3rata-rata 5T ≈1.1 | ≈1.1 | 6.6 | Likuiditas rendah | |
| Quick Ratio (Rasio Cepat) | 1.6rata-rata 5T ≈0.8 | ≈0.8 | 3.9 | Likuiditas rendah |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | NVAX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 64.7%rata-rata 5T ≈39.5% | ≈39.5% | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | -17.2%rata-rata 5T ≈-1.9% | ≈-1.9% | · | · | |
| Revenue CAGR 5Y (CAGR Pendapatan 5T) | 18.8% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | NVAX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.8rata-rata 5T ≈0.6 | ≈0.6 | 0.3 | Tingkat teratas | |
| Inventory Turnover (Perputaran Persediaan) | 7.2rata-rata 5T ≈15.9 | ≈15.9 | · | · | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$1.5M | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
224.4%
Laporan Berikutnya
Nov 04, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 12, 2026 | $-0.32 | $-0.39 | 18.6% |
| 31 Maret 2026 | Mei 13, 2026 | $-0.06 | $-0.23 | 74.5% |
| 31 Des. 2025 | $0.11 | $-0.50 | 122.1% | |
| 30 Sep. 2025 | $-1.25 | $-1.21 | -3.3% | |
| 30 Juni 2025 | $0.62 | $-0.09 | 827.7% | |
| 31 Maret 2025 | $2.93 | $0.72 | 306.9% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.12B | $682M | $984M | $1.98B | $1.15B | $476M | $19M | $34M | $31M | $15M | $36M | $31M | |
| Cost of Revenue | $73M | $203M | $344M | $903M | $0 | $0 | · | · | · | · | · | · | |
| R&D Expense | $342M | $391M | $738M | $1.24B | $2.53B | $747M | $114M | $174M | $168M | $238M | $163M | $94M | |
| SG&A Expense | $157M | $337M | $469M | $489M | $298M | $145M | $34M | $34M | $34M | $47M | $31M | $20M | |
| Operating Expenses | $671M | $931M | $1.55B | $2.63B | $2.83B | $892M | $139M | $208M | $203M | $284M | $193M | $114M | |
| Operating Income | $453M | $-249M | $-567M | $-645M | $-1.69B | $-417M | $-121M | $-174M | $-172M | $-269M | $-157M | $-84M | |
| Interest Expense | · | · | $14M | $20M | $21M | $15M | $14M | $14M | $14M | $13M | $241.0K | $157.0K | |
| Interest Income | $30M | $37M | $20M | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $41M | $40M | $38M | $11M | $-7M | $14M | $-13.0K | $108.0K | $67.0K | $-31.0K | $-120.0K | $0 | |
| Pretax Income | $442M | $-177M | $-543M | $-654M | $-1.71B | $-418M | $-133M | · | · | · | $-157M | $-83M | |
| Income Tax | $2M | $11M | $2M | $4M | $29M | $0 | $0 | · | · | · | $0 | $0 | |
| Net Income | $440M | $-187M | $-545M | $-658M | $-1.74B | $-418M | $-133M | $-185M | $-184M | $-280M | $-157M | $-83M | |
| EPS (Basic) | $2.72 | $-1.23 | $-5.41 | $-8.42 | $-23.44 | $-7.27 | $-5.51 | · | · | · | · | · | |
| EPS (Diluted) | $2.58 | $-1.23 | $-5.41 | $-8.42 | $-23.44 | $-7.27 | $-5.51 | · | · | · | · | · | |
| Shares (Basic) | 161,991,000 | 152,190,000 | 100,768,000 | 78,183,000 | 74,400,000 | 57,554,000 | 24,100,000 | · | · | · | · | · | |
| Shares (Diluted) | 173,103,000 | 152,190,000 | 100,768,000 | 78,183,000 | 74,400,000 | 57,554,000 | 24,100,000 | · | · | · | · | · | |
| EBITDA | $481M | $-201M | $-526M | $-616M | $-1.67B | · | · | · | $-164M | $-261M | $-151M | $-79M |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $241M | $530M | $569M | $1.34B | $1.52B | $553M | $79M | $70M | $106M | $144M | $93M | $32M | |
| Short-term Investments | $494M | $393M | $0 | · | $0 | $158M | $0 | $22M | $51M | $91M | $138M | $136M | |
| Receivables | · | · | · | · | $455M | $262M | $8M | · | · | $233.0K | $2M | $8M | |
| Inventory | $12M | $9M | $42M | $37M | $9M | · | · | · | · | · | · | · | |
| Prepaid Expense | $27M | $78M | $226M | $237M | $165M | $181M | $8M | $16M | $18M | $22M | $19M | $9M | |
| Other Current Assets | $10M | $22M | $156M | $76M | $45M | $10M | $4M | $4M | $5M | $6M | $6M | $2M | |
| Current Assets | $978M | $1.13B | $1.14B | $1.70B | $2.16B | $1.25B | $97M | $119M | $203M | $288M | $287M | $188M | |
| PP&E (Net) | $45M | $138M | $306M | $294M | $226M | $180M | $11M | $28M | $36M | $40M | $32M | $20M | |
| PP&E (Gross) | $85M | $188M | $381M | $342M | $252M | $198M | $24M | $64M | $65M | $62M | $48M | $31M | |
| Accum. Depreciation | $41M | $49M | $75M | $47M | $26M | $18M | $13M | $36M | $29M | $22M | $16M | $11M | |
| Goodwill | $113M | $107M | $127M | $126M | $131M | $135M | $51M | $52M | $54M | $52M | $53M | $55M | |
| Intangibles | · | · | · | · | $5M | $6M | $6M | $7M | $8M | $9M | $11M | $13M | |
| Other Non-current Assets | $17M | $24M | $35M | $28M | $24M | $13M | $7M | $810.0K | $869.0K | $799.0K | $159.0K | $918.0K | |
| Total Assets | $1.18B | $1.56B | $1.80B | $2.26B | $2.58B | $1.58B | $173M | $208M | $302M | $394M | $386M | $276M | |
| Accounts Payable | $25M | $42M | $133M | $217M | $127M | $54M | $3M | $9M | $6M | $6M | $12M | $13M | |
| Accrued Liabilities | $107M | $211M | $395M | $591M | $674M | $137M | $15M | $20M | $30M | $25M | $27M | $19M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | $0 | $395.0K | $603.0K | |
| Current Liabilities | $460M | $1.15B | $1.64B | $2.46B | $2.39B | $580M | $26M | $46M | $74M | $66M | $76M | $34M | |
| Capital Leases | $19M | $23M | $29M | $50M | $39M | $10M | · | · | · | · | · | · | |
| Other Non-current Liabilities | $239M | $360M | $33M | $56M | $42M | $13M | $13M | $9M | $10M | $15M | $13M | $2M | |
| Total Liabilities | $1.30B | $2.18B | $2.51B | $2.89B | $2.93B | $955M | $359M | $376M | $404M | $400M | $93M | $46M | |
| Long-term Debt | $244M | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | · | · | · | · | · | · | · | · | · | $0 | $395.0K | $603.0K | |
| Common Stock | $2M | $2M | $1M | $868.0K | $764.0K | $714.0K | $324.0K | $192.0K | $3M | $3M | $3M | $2M | |
| Paid-in Capital | $4.54B | $4.50B | $4.19B | $3.74B | $3.35B | $2.54B | $1.26B | $1.14B | $1.02B | $936M | $952M | $729M | |
| Retained Earnings | $-4.57B | $-5.01B | $-4.82B | $-4.28B | $-3.62B | $-1.87B | $-1.43B | $-1.30B | $-1.11B | $-930M | $-650M | $-493M | |
| Treasury Stock | $103M | $96M | $92M | $91M | $85M | $42M | $3M | $2M | $2M | $2M | $2M | $2M | |
| AOCI | $2M | $-23M | $3M | $-6M | $-1M | $7M | $-13M | $-11M | $-9M | $-12M | $-9M | $-7M | |
| Stockholders' Equity | $-128M | $-624M | $-717M | $-634M | $-352M | $627M | $-186M | $-168M | $-102M | $-6M | $293M | $230M | |
| Liabilities + Equity | $1.18B | $1.56B | $1.80B | $2.26B | $2.58B | $1.58B | $173M | $208M | $302M | $394M | $386M | $276M | |
| Shares Outstanding | 162,575,937 | 161,942,677 | 140,506,093 | 86,806,554 | 76,433,151 | 71,350,365 | 32,352,416 | 19,222,410 | 323,229,390 | 271,245,967 | 269,971,232 | 238,831,864 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $28M | $48M | $41M | $29M | $13M | $4M | $5M | $7M | $8M | $8M | $5M | $4M | |
| Stock-based Comp | $36M | $48M | $85M | $130M | $184M | $128M | $17M | $18M | $20M | $19M | $13M | $6M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Amort. of Intangibles | · | · | · | · | $400.0K | $600.0K | $700.0K | $700.0K | $2M | $800.0K | $900.0K | $1M | |
| Restructuring | · | · | $15M | $0 | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-749M | $4M | $-295M | $83M | $1.87B | · | · | · | $18M | $-3M | $11M | $5M | |
| Operating Cash Flow | $-245M | $-87M | $-714M | $-416M | $323M | $-43M | $-137M | $-185M | $-144M | $-259M | $-126M | $-67M | |
| CapEx | · | · | · | · | $57M | $55M | $2M | $1M | $4M | $18M | $18M | $7M | |
| Investing Cash Flow | $-78M | $-204M | $-59M | $-93M | $100M | $-378M | $38M | $29M | $36M | $28M | $-21M | · | |
| Stock Issued | $0 | $263M | $360M | $249M | $565M | $876M | $97M | $100M | $63M | $0 | $204M | $108M | |
| Net Stock Activity | $0 | $263M | $360M | $249M | $565M | · | · | · | $63M | $0 | $204M | $108M | |
| Financing Cash Flow | $28M | $261M | $4M | $325M | $462M | $985M | $98M | $103M | $65M | $280M | $208M | · | |
| Net Change in Cash | $-289M | $-39M | $-765M | $-179M | $880M | $567M | $221.0K | $-53M | $-44M | $49M | $61M | $-87M | |
| Taxes Paid | $9M | $949.0K | $190.0K | $18M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | $265M | · | · | · | $-143M | $-274M | $-144M | $-74M | |
| Levered FCF | · | · | · | · | $244M | · | · | · | · | · | $-145M | $-74M |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 40.3% | -36.5% | -57.6% | -32.5% | -147.1% | · | · | · | -550.8% | -1752.8% | -433.8% | -273.0% | |
| Net Margin | 39.2% | -27.5% | -55.4% | -33.2% | -152.1% | · | · | · | -589.5% | -1823.5% | -432.9% | -270.5% | |
| Pretax Margin | 39.4% | -25.9% | -55.2% | -33.0% | -149.6% | · | · | · | · | · | -432.9% | -270.5% | |
| EBITDA Margin | 42.8% | -29.5% | -53.4% | -31.1% | -146.0% | · | · | · | -526.4% | -1697.5% | -417.2% | -258.6% | |
| ROA | 32.2% | -11.2% | -26.9% | -27.2% | -83.9% | · | · | · | -52.8% | -71.8% | -47.4% | -32.5% | |
| ROE | -977.1% | 32.6% | 78.1% | 109.7% | -3180.2% | · | · | · | 342.6% | -195.0% | -60.1% | -38.3% | |
| ROIC | -352.9% | 42.4% | 79.3% | 102.4% | 487.8% | · | · | · | · | · | -53.6% | -36.4% |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 1.0 | 0.7 | 0.7 | 0.9 | · | · | · | 2.8 | 4.3 | 3.8 | 5.5 | |
| Quick Ratio | 1.6 | 0.8 | 0.3 | 0.5 | 0.8 | · | · | · | 2.1 | 3.5 | 3.0 | 5.1 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | |
| Interest Coverage | · | · | -39.3 | -32.4 | -79.8 | · | · | · | -12.2 | -20.8 | -652.4 | -533.1 |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.4 | 0.5 | 0.8 | 0.6 | · | · | · | 0.1 | 0.0 | 0.1 | 0.1 | |
| Inventory Turnover | 7.2 | 8.0 | 8.8 | 39.6 | · | · | · | · | · | · | · | · | |
| Receivables Turnover | · | · | · | · | 3.2 | · | · | · | · | 12.0 | 8.1 | 6.5 |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.79 | $-3.89 | $-5.14 | $-7.37 | $-4.64 | · | · | · | $-0.31 | $-0.02 | $1.08 | $0.96 | |
| Revenue / Share | $6.49 | $4.48 | $9.76 | $25.35 | $15.41 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-1.41 | $-0.57 | $-7.09 | $-5.32 | $4.34 | · | · | · | · | · | · | · | |
| Cash / Share | $1.48 | $3.31 | $4.08 | $15.54 | $19.98 | · | · | · | $0.33 | $0.53 | $0.34 | $0.14 | |
| EPS (TTM) | $2.58 | $-1.23 | $-5.41 | $-8.42 | $-23.44 | $-7.27 | $-5.51 | · | · | · | · | · |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 64.7% | -30.6% | -50.4% | 72.9% | 141.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -17.2% | -15.9% | 27.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 18.8% | · | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.12B | $682M | $984M | $1.98B | $1.15B | $476M | $19M | $34M | $31M | $15M | $36M | $31M | |
| Net Income TTM | $440M | $-187M | $-545M | $-658M | $-1.74B | $-418M | $-133M | $-185M | $-184M | $-280M | $-157M | $-83M | |
| Market Cap | $1.09B | $1.29B | $670M | $884M | $10.85B | · | · | · | $8.02B | $6.84B | $45.30B | $28.33B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | $6.60B | $45.07B | $28.16B | |
| P/E | 2.6 | -6.5 | -0.9 | -1.2 | -6.1 | -15.3 | -0.7 | · | · | · | · | · | |
| P/S | 1.0 | 1.9 | 0.7 | 0.4 | 9.5 | · | · | · | 257.1 | 445.2 | 1249.7 | 923.9 | |
| P/B | -8.6 | -2.1 | -0.9 | -1.4 | -30.9 | · | · | · | -78.8 | -1232.5 | 154.8 | 123.4 | |
| P / Tangible Book | · | · | · | · | · | 16.3 | · | · | · | · | · | · | |
| P / Cash Flow | -4.5 | -14.8 | -0.9 | -2.1 | 33.6 | · | · | · | -57.8 | -26.8 | -359.3 | -422.7 | |
| P / FCF | · | · | · | · | 40.9 | · | · | · | -56.1 | -25.0 | -313.8 | -381.3 | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | -25.3 | -298.0 | -355.1 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | -24.1 | -312.2 | -379.1 | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | 429.9 | 1243.3 | 918.4 | |
| Earnings Yield | 38.4% | -15.3% | -112.7% | -81.9% | -16.4% | -6.5% | -138.4% | · | · | · | · | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $57M | $140M | $147M | $70M | $239M | $667M | $88M | $85M | $415M | $94M | $291M | $187M | $424M | $81M | $357M | $735M | |
| Cost of Revenue | $14M | $31M | $22M | $21M | $15M | $14M | $37M | $61M | $46M | $59M | $155M | $99M | $56M | $34M | $182M | $435M | |
| R&D Expense | $71M | $95M | $76M | $98M | $79M | $89M | $104M | $87M | $107M | $93M | $165M | $106M | $219M | $247M | $258M | $304M | |
| SG&A Expense | $27M | $29M | $34M | $32M | $44M | $48M | $78M | $71M | $101M | $87M | $155M | $107M | $94M | $113M | $162M | $123M | |
| Operating Expenses | $112M | $155M | $133M | $248M | $138M | $151M | $219M | $219M | $254M | $239M | $475M | $313M | $369M | $394M | $601M | $862M | |
| Operating Income | $-55M | $-15M | $14M | $-178M | $101M | $516M | $-131M | $-134M | $161M | $-145M | $-184M | $-126M | $55M | $-313M | $-244M | $-127M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $4M | · | $3M | $3M | $4M | · | $4M | |
| Interest Income | $7M | $7M | $7M | $7M | $7M | $8M | $9M | $12M | $9M | · | · | · | · | · | · | · | |
| Other Non-op | $9M | $12M | $9M | $9M | $12M | $10M | $13M | $16M | $8M | $4M | $11M | $-3M | $6M | $24M | $64M | $-35M | |
| Pretax Income | $-52M | $-9M | $18M | $-203M | $107M | $520M | $-74M | $-122M | $165M | $-145M | $-177M | $-131M | $58M | $-293M | $-185M | $-166M | |
| Income Tax | $2M | $985.0K | $376.0K | $-657.0K | $946.0K | $1M | $7M | $-1M | $2M | $2M | $2M | $-697.0K | $-143.0K | $1M | $-2M | $2M | |
| Net Income | $-53M | $-9M | $18M | $-202M | $107M | $519M | $-81M | $-121M | $162M | $-148M | $-178M | $-131M | $58M | $-294M | $-182M | $-169M | |
| EPS (Basic) | $-0.32 | $-0.06 | $0.09 | $-1.25 | $0.66 | $3.22 | $-0.51 | $-0.76 | $1.09 | $-1.05 | $-1.39 | $-1.26 | $0.65 | $-3.41 | $-2.40 | $-2.15 | |
| EPS (Diluted) | $-0.32 | $-0.06 | $0.28 | $-1.25 | $0.62 | $2.93 | $-0.41 | $-0.76 | $0.99 | $-1.05 | $-1.32 | $-1.26 | $0.58 | $-3.41 | $-2.30 | $-2.15 | |
| Shares (Basic) | 164,574,000 | 163,276,000 | · | 162,353,000 | 162,019,000 | 161,049,000 | · | 160,049,000 | 148,379,000 | 139,916,000 | · | 103,429,000 | 89,362,000 | 86,158,000 | · | 78,274,000 | |
| Shares (Diluted) | 164,574,000 | 163,276,000 | · | 162,353,000 | 177,215,000 | 177,625,000 | · | 160,049,000 | 165,855,000 | 139,916,000 | · | 103,429,000 | 104,065,000 | 86,158,000 | · | 78,274,000 | |
| EBITDA | $-55M | $-15M | · | $-178M | $101M | $516M | · | $-134M | $161M | $-145M | · | $-126M | $55M | $-313M | · | $-127M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $191M | $228M | $241M | $268M | $254M | $263M | $530M | $574M | $680M | $481M | $569M | $651M | $506M | $625M | $1.34B | $1.28B | |
| Short-term Investments | $528M | $562M | $494M | $495M | $359M | $468M | $393M | $336M | $369M | · | · | · | · | · | · | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $112M | |
| Inventory | $10M | $11M | $12M | $14M | $10M | $10M | $9M | $9M | $9M | $16M | · | $70M | $23M | $34M | · | $82M | |
| Prepaid Expense | $23M | $26M | $27M | $46M | $60M | $71M | $78M | $80M | $102M | $199M | · | $152M | $193M | $189M | · | $275M | |
| Other Current Assets | · | · | $10M | · | · | · | $22M | · | · | · | · | · | · | · | · | · | |
| Current Assets | $771M | $851M | $978M | $975M | $920M | $868M | $1.13B | $1.10B | $1.20B | $727M | · | $1.01B | $1.13B | $971M | · | $1.76B | |
| PP&E (Net) | $38M | $42M | $45M | $49M | $130M | $134M | $138M | $286M | $289M | $291M | · | $301M | $300M | $307M | · | $256M | |
| PP&E (Gross) | · | · | $85M | · | · | · | $188M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $41M | · | · | · | $49M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $113M | $113M | $113M | $113M | $113M | $112M | $107M | $127M | $123M | $123M | $127M | $124M | $128M | $130M | $126M | $118M | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $8M | |
| Other Non-current Assets | $14M | $16M | $17M | $19M | $21M | $22M | $24M | $31M | $34M | $31M | · | $35M | $33M | $31M | · | $17M | |
| Total Assets | $956M | $1.04B | $1.18B | $1.18B | $1.34B | $1.29B | $1.56B | $1.71B | $1.82B | $1.35B | · | $1.66B | $1.69B | $1.54B | · | $2.27B | |
| Accounts Payable | $23M | $16M | $25M | $15M | $51M | $34M | $42M | $58M | $80M | $58M | · | $102M | $87M | $125M | · | $145M | |
| Accrued Liabilities | $81M | $103M | $107M | $116M | $87M | $132M | $211M | $219M | $159M | $257M | · | $311M | $458M | $519M | · | $551M | |
| Current Liabilities | $331M | $342M | $460M | $430M | $389M | $422M | $1.15B | $1.18B | $1.16B | $804M | · | $1.47B | $1.60B | $1.92B | · | $1.67B | |
| Capital Leases | · | · | $19M | · | · | · | $23M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $166M | $193M | $239M | $263M | $288M | $314M | $360M | $319M | $335M | $352M | · | $37M | $38M | $48M | · | $99M | |
| Total Liabilities | $1.15B | $1.19B | $1.30B | $1.34B | $1.30B | $1.37B | $2.18B | $2.24B | $2.25B | $2.22B | · | $2.34B | $2.44B | $2.44B | · | $2.83B | |
| Long-term Debt | $291M | $291M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | · | $1M | $952.0K | $871.0K | · | $792.0K | |
| Paid-in Capital | $4.56B | $4.55B | $4.54B | $4.53B | $4.52B | $4.51B | $4.50B | $4.49B | $4.48B | $4.20B | · | $4.07B | $3.86B | $3.77B | · | $3.64B | |
| Retained Earnings | $-4.63B | $-4.58B | $-4.57B | $-4.59B | $-4.38B | $-4.49B | $-5.01B | $-4.93B | $-4.81B | $-4.97B | · | $-4.64B | $-4.51B | $-4.57B | · | $-4.09B | |
| Treasury Stock | $112M | $112M | $103M | $103M | $102M | $102M | $96M | $95M | $94M | $94M | · | $92M | $91M | $91M | · | $90M | |
| AOCI | $-7M | $-5M | $2M | $-2M | $-458.0K | $2M | $-23M | $4M | $-11M | $-11M | · | $-12M | $-8M | $-3M | · | $-24M | |
| Stockholders' Equity | $-191M | $-145M | $-128M | $-157M | $38M | $-76M | $-624M | $-526M | $-432M | $-867M | $-717M | $-678M | $-755M | $-896M | $-634M | $-566M | |
| Liabilities + Equity | $956M | $1.04B | $1.18B | $1.18B | $1.34B | $1.29B | $1.56B | $1.71B | $1.82B | $1.35B | · | $1.66B | $1.69B | $1.54B | · | $2.27B | |
| Shares Outstanding | 164,815,529 | 164,422,575 | 162,575,937 | 162,470,138 | 162,155,109 | 161,957,868 | 160,421,136 | 160,148,088 | 159,891,014 | 140,373,255 | 140,506,093 | 118,730,398 | 94,308,379 | 86,291,473 | 86,806,554 | 78,476,814 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $5M | $7M | $8M | $8M | $13M | $13M | $11M | $12M | $11M | $11M | $10M | $9M | $7M | $8M | |
| Stock-based Comp | $8M | $8M | $8M | $9M | $9M | $10M | $10M | $12M | $14M | $12M | $16M | $21M | $20M | $29M | $28M | $32M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $400.0K | |
| Restructuring | · | · | · | · | · | $500.0K | · | · | $1M | $6M | · | $-140.0K | $15M | · | · | · | |
| Operating Cash Flow | $-73M | $-32M | $-39M | $108M | $-127M | $-186M | $-173M | $-145M | $314M | $-84M | $-177M | $-40M | $-172M | $-326M | $-118M | $-39M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $25M | |
| Investing Cash Flow | $35M | $-28M | $20M | $-137M | $111M | $-73M | $144M | $32M | $-373M | $-7M | $-9M | $-18M | $-8M | $-24M | $-22M | $-30M | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $256M | $7M | $103M | $195M | $62M | $0 | $70M | $0 | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $7M | · | · | · | $0 | · | · | |
| Financing Cash Flow | $1M | $38M | $-7M | $42M | $-1M | $-7M | $-3M | $-97.0K | $258M | $6M | $100M | $197M | $61M | $-354M | $191M | $-31M | |
| Net Change in Cash | $-37M | $-23M | $-27M | $14M | $-9M | $-267M | $-43M | $-107M | $200M | $-88M | $-83M | $148M | $-119M | $-712M | $56M | $-94M | |
| Taxes Paid | $985.0K | $2M | $6.0K | $4M | $3M | $1M | $308.0K | $1M | $-578.0K | $-71.0K | $62.0K | $0 | $128.0K | $0 | $137.0K | $65.0K |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -96.8% | -11.1% | · | -252.7% | 42.2% | 77.3% | · | -158.6% | 38.8% | -154.3% | · | -67.2% | 13.1% | -386.4% | · | -17.3% | |
| Net Margin | -94.2% | -6.8% | · | -287.3% | 44.5% | 77.8% | · | -143.5% | 39.1% | -157.2% | · | -69.9% | 13.7% | -363.1% | · | -22.9% | |
| Pretax Margin | -91.1% | -6.1% | · | -288.2% | 44.9% | 78.0% | · | -144.8% | 39.6% | -154.8% | · | -70.3% | 13.6% | -361.6% | · | -22.6% | |
| EBITDA Margin | -96.8% | -11.1% | · | -252.7% | 42.2% | 77.3% | · | -158.6% | 38.8% | -154.3% | · | -67.2% | 13.1% | -386.4% | · | -17.3% | |
| ROA | -4.7% | -0.81% | · | -14.0% | 6.8% | 39.2% | · | -7.2% | 9.3% | -10.2% | · | -6.7% | 2.7% | -13.4% | · | -7.0% | |
| ROE | 69.8% | 8.6% | · | 59.2% | -54.0% | -110.0% | · | 20.1% | -27.4% | 16.7% | · | 21.0% | -9.9% | 70.8% | · | 322.2% | |
| ROIC | 29.7% | 11.9% | · | 113.3% | 266.3% | -679.9% | · | 25.2% | -36.8% | 17.0% | · | 18.4% | -7.4% | 35.1% | · | 22.8% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.3 | 2.5 | · | 2.3 | 2.4 | 2.1 | · | 0.9 | 1.0 | 0.9 | · | 0.7 | 0.7 | 0.5 | · | 1.1 | |
| Quick Ratio | 2.2 | 2.3 | · | 1.8 | 1.6 | 1.7 | · | 0.8 | 0.9 | 0.6 | · | 0.4 | 0.3 | 0.3 | · | 0.8 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -35.2 | · | -43.9 | 17.8 | -72.5 | · | -30.5 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | · | 0.0 | 0.2 | 0.5 | · | 0.1 | 0.2 | 0.1 | · | 0.1 | 0.2 | 0.0 | · | 0.3 | |
| Inventory Turnover | 1.4 | 2.8 | · | 1.9 | 1.6 | 1.1 | · | 1.5 | 2.8 | 2.4 | · | 1.3 | 0.4 | 0.5 | · | 10.5 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 7.9 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-1.16 | $-0.88 | · | $-0.96 | $0.23 | $-0.47 | · | $-3.29 | $-2.70 | $-6.18 | · | $-5.71 | $-8.00 | $-10.38 | · | $-7.21 | |
| Revenue / Share | $0.34 | $0.85 | · | $0.43 | $1.35 | $3.75 | · | $0.53 | $2.51 | $0.67 | · | $1.81 | $4.08 | $0.94 | · | · | |
| Cash Flow / Share | · | $-0.20 | · | · | · | $-1.04 | · | · | · | $-0.60 | · | · | · | $-3.78 | · | · | |
| Cash / Share | $1.16 | $1.39 | · | $1.65 | $1.56 | $1.63 | · | $3.58 | $4.25 | $3.42 | · | $5.48 | $5.36 | $7.24 | · | $16.32 | |
| EPS (TTM) | $-1.35 | $-0.41 | · | $1.89 | $2.38 | $2.75 | · | $-2.14 | $-2.64 | $-3.05 | · | $-6.39 | $-7.28 | $-14.39 | · | $-17.45 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $414M | $596M | · | $1.06B | $1.08B | $1.25B | · | $885M | $988M | $997M | · | $1.05B | $1.60B | $1.36B | · | $1.85B | |
| Net Income TTM | $-248M | $-88M | · | $342M | $423M | $479M | · | $-285M | $-294M | $-399M | · | $-549M | $-587M | $-1.16B | · | $-1.32B | |
| Market Cap | $1.55B | $1.34B | · | $1.41B | $1.02B | $1.04B | · | $2.02B | $2.02B | $671M | · | $860M | $701M | $598M | · | $1.43B | |
| P/E | -7.0 | -19.9 | · | 4.6 | 2.6 | 2.3 | · | -5.9 | -4.8 | -1.6 | · | -1.1 | -1.0 | -0.5 | · | -1.0 | |
| P/S | 3.8 | 2.2 | · | 1.3 | 0.9 | 0.8 | · | 2.3 | 2.0 | 0.7 | · | 0.8 | 0.4 | 0.4 | · | 0.8 | |
| P/B | -8.1 | -9.2 | · | -9.0 | 27.2 | -13.7 | · | -3.8 | -4.7 | -0.8 | · | -1.3 | -0.9 | -0.7 | · | -2.5 | |
| P / Cash Flow | · | -41.3 | · | · | · | -5.6 | · | · | · | -8.0 | · | · | · | -1.8 | · | · | |
| Earnings Yield | -14.3% | -5.0% | · | 21.8% | 37.8% | 42.9% | · | -16.9% | -20.8% | -63.8% | · | -88.3% | -98.0% | -207.6% | · | -95.9% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $1.12B | $682M | $984M | $1.98B | $1.15B |
| Margin Operasi % | 40.3% | -36.5% | -57.6% | -32.5% | -147.1% |
| Laba Bersih | $440M | $-187M | $-545M | $-658M | $-1.74B |
| EPS Dilusian | $2.58 | $-1.23 | $-5.41 | $-8.42 | $-23.44 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 2.1 | 1.0 | 0.7 | 0.7 | 0.9 |
| Rasio Cepat | 1.6 | 0.8 | 0.3 | 0.5 | 0.8 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | · | · | · | · | $265M |
Pemilik institusional (13F) 314 pengaju · $1.3B total · Per tanggal 30 Sep. 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
314
Nilai yang dipegang
$1.3B
Posisi baru
45
Posisi yang keluar
28
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 45 (-15 vs Kuartal sebelumnya) | 28 (-4 vs Kuartal sebelumnya) | 87 (+14 vs Kuartal sebelumnya) | 91 (+3 vs Kuartal sebelumnya) | +1.0M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| SHAH CAPITAL MANAGEMENT | $133.439.735 | 14.165.577 | 10,17% | Saham |
| BlackRock, Inc. | $131.379.618 | 13.946.881 | 10,02% | Saham |
| STATE STREET CORP | $110.595.981 | 11.740.550 | 8,43% | Saham |
| VANGUARD GROUP INC | $103.960.853 | 15.470.365 | 7,93% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $71.667.322 | 7.607.996 | 5,46% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $68.365.170 | 7.257.449 | 5,21% | Saham |
| Sanofi | $64.814.131 | 6.880.481 | 4,94% | Saham |
| D. E. Shaw & Co., Inc. | $53.231.525 | 5.650.905 | 4,06% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $39.641.825 | 4.207.370 | 3,02% | Saham |
| TWO SIGMA INVESTMENTS, LP | $38.537.625 | 4.091.043 | 2,94% | Saham |
| COATUE MANAGEMENT LLC | $36.144.408 | 3.836.986 | 2,76% | Saham |
| BANK OF AMERICA CORP /DE/ | $32.180.934 | 3.416.235 | 2,45% | Saham |
| GOLDMAN SACHS GROUP INC | $28.333.064 | 3.007.756 | 2,16% | Saham |
| Graham Capital Management, L.P. | $19.655.772 | 2.086.600 | 1,50% | Opsi jual |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18.572.472 | 1.971.600 | 1,42% | Opsi beli |
| UBS Group AG | $17.612.188 | 1.869.659 | 1,34% | Saham |
| MILLENNIUM MANAGEMENT LLC | $16.656.095 | 1.768.163 | 1,27% | Saham |
| CITADEL ADVISORS LLC | $15.969.848 | 1.695.313 | 1,22% | Saham |
| CITADEL ADVISORS LLC | $15.409.236 | 1.635.800 | 1,17% | Opsi jual |
| Allianz Asset Management GmbH | $14.876.064 | 1.579.200 | 1,13% | Saham |
| NORTHERN TRUST CORP | $13.641.178 | 1.448.108 | 1,04% | Saham |
| TSP Capital Management Group, LLC | $13.370.420 | 1.419.365 | 1,02% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $12.685.038 | 1.346.607 | 0,97% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $10.221.642 | 1.085.100 | 0,78% | Saham |
| JUPITER ASSET MANAGEMENT LTD | $10.081.585 | 1.070.232 | 0,77% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $8.604.228 | 913.400 | 0,66% | Opsi jual |
| AQR CAPITAL MANAGEMENT LLC | $8.502.964 | 902.650 | 0,65% | Saham |
| Bank of New York Mellon Corp | $8.004.342 | 849.718 | 0,61% | Saham |
| FEDERATED HERMES, INC. | $6.622.316 | 703.006 | 0,50% | Saham |
| Point72 Asset Management, L.P. | $6.257.574 | 664.286 | 0,48% | Saham |
| MARSHALL WACE, LLP | $6.149.123 | 652.773 | 0,47% | Saham |
| FMR LLC | $5.735.877 | 608.904 | 0,44% | Saham |
| Monaco Asset Management SAM | $5.439.711 | 577.464 | 0,41% | Saham |
| Edgestream Partners, L.P. | $5.273.278 | 559.796 | 0,40% | Saham |
| CITIGROUP INC | $4.834.353 | 513.201 | 0,37% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.767.302 | 506.083 | 0,36% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $4.726.796 | 501.783 | 0,36% | Saham |
| CITADEL ADVISORS LLC | $4.518.774 | 479.700 | 0,34% | Opsi beli |
| CITIGROUP INC | $4.443.414 | 471.700 | 0,34% | Opsi beli |
| MORGAN STANLEY | $4.394.030 | 466.456 | 0,34% | Saham |
| Trexquant Investment LP | $4.349.610 | 461.742 | 0,33% | Saham |
| TUDOR INVESTMENT CORP ET AL | $4.115.598 | 436.900 | 0,31% | Opsi beli |
| DIMENSIONAL FUND ADVISORS LP | $3.737.018 | 396.711 | 0,28% | Saham |
| FIRST TRUST ADVISORS LP | $3.633.284 | 385.699 | 0,28% | Saham |
| UBS Group AG | $3.499.643 | 371.512 | 0,27% | Opsi beli |
| Nuveen, LLC | $3.263.229 | 346.415 | 0,25% | Saham |
| JANE STREET GROUP, LLC | $2.700.714 | 286.700 | 0,21% | Opsi beli |
| GROUP ONE TRADING LLC | $2.673.594 | 283.821 | 0,20% | Saham |
| ALGERT GLOBAL LLC | $2.618.666 | 277.990 | 0,20% | Saham |
| Swiss National Bank | $2.617.818 | 277.900 | 0,20% | Saham |
Aktivis & pemilik 5%+ 11 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Shah Capital Management, Shah Capital Opportunity Fund LP, Himanshu H. Shah ×7 pengajuan | 15 Mei 2026 | 9,03% | Amandemen | · | SEC |
| Shah Capital Management, Inc., Shah Capital Opportunity Fund LP, Himanshu H. Shah ×2 pengajuan | 20 Mei 2024 | · | Pengajuan awal | · | SEC |
| Dr. Rajiv I. Modi, Cadila Pharmaceuticals Ltd, Satellite Overseas (Holdings) Limited ×3 pengajuan | 21 Maret 2014 | · | Pengajuan awal | · | SEC |
| KPCB Holdings, Inc., KPCB Pandemic and Bio Defense Fund, LLC, KPCB PBD Associates, LLC | 10 Maret 2006 | · | Pengajuan awal | Investasi pasif | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 4 Nov. 2005 | · | Pengajuan awal | · | SEC |
| King Pharmaceuticals, Inc. ×2 pengajuan | 13 Okt. 2005 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 6 Sep. 2005 | · | Pengajuan awal | Investasi pasif | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 26 Feb. 2003 | · | Pengajuan awal | Investasi pasif | SEC |
| S.S. or King Pharmaceuticals, Inc. | 24 Juli 2002 | · | Pengajuan awal | Investasi pasif | SEC |
| Orang pelapor yang tidak diungkapkan | 19 Sep. 2001 | · | Pengajuan awal | Investasi pasif | SEC |
| Anaconda Opportunity Fund, L.P., Anaconda Capital, L.P., Mitchell J. Kelly ×2 pengajuan | 10 April 2001 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 52 orang dalam · 27 pejabat · 25 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| John C Jacobs | President and CEO | 2 Maret 2026 A | 225.680 | 0 | 0 | $0 |
| Stanley C Erck | President and CEO | 14 Des. 2022 M | 36.492 | 0 | 0 | $0 |
| Rahul Singhvi | President, CEO | 10 Maret 2011 A | 113.104 | 0 | 0 | $0 |
| James Patrick Kelly | EVP, CFO and Treasurer | 7 Maret 2026 M | 130.599 | 0 | 0 | $0 |
| Gregory F Covino | EVP, Chief Financial Officer | 16 Nov. 2020 A | · | 0 | 0 | $0 |
| Barclay A Phillips | SVP, Chief Financial Officer | 31 Juli 2017 P | 38.669 | 0 | 0 | $0 |
| Frederick W Driscoll | VP, CFO & Treasurer | 2 Maret 2013 A | 20.000 | 0 | 0 | $0 |
| Len F Stigliano | VP, CFO, Treasurer | 31 Juli 2008 P | 20.554 | 0 | 0 | $0 |
| Jeffrey Wayne Church | VP, CFO, Treasurer & Corp. Sec | 7 Maret 2007 A | · | 0 | 0 | $0 |
| Dennis W Genge | VP, Treasurer,CFO | 17 Feb. 2006 A | 6.400 | 0 | 0 | $0 |
| John Trizzino | President and COO | 7 Maret 2025 M | 68.061 | 0 | 0 | $0 |
| Filip Dubovsky | President, R&D | 17 Juni 2024 M | 66.613 | 0 | 0 | $0 |
| Gregory M Glenn | President, R&D | 10 Maret 2023 M | 18.339 | 0 | 0 | $0 |
| Robert Edward Walker | EVP, R&D | 14 April 2026 A | · | 0 | 0 | $0 |
| Ruxandra Draghia-Akli | EVP, Research & Development | 2 Maret 2026 A | 23.563 | 0 | 0 | $0 |
| Elaine O'Hara | EVP, Chief Strategy Officer | 2 Maret 2026 A | 134.642 | 0 | 0 | $0 |
| Mark J Casey | EVP, Chief Legal Officer | 2 Maret 2026 A | 90.067 | 0 | 0 | $0 |
| John A Herrmann III | EVP, Chief Legal Officer | 14 Des. 2023 M | 13.233 | 0 | 0 | $0 |
| Timothy Jon Hahn | SVP, Manufacturing | 5 Maret 2015 A | 110.485 | 0 | 0 | $0 |
| Wilson Russell P | SVP, Business Development | 5 Maret 2015 A | 64.939 | 0 | 0 | $0 |
| Thomas Scott Johnston | Vice President, Strategy | 15 Maret 2010 A | 11.000 | 0 | 0 | $0 |
| Penny Heaton | VP & Chief Medical Officer | 2 Juli 2009 S | 18.667 | 0 | 0 | $0 |
| Evdoxia E Kopsidas | Sr.Dir.Fin.,Prin.Acctg.Officer | 17 Juni 2009 A | · | 0 | 0 | $0 |
| Jim Robinson | VP, Technical & Quality Ops. | 5 Maret 2009 A | 77.590 | 0 | 0 | $0 |
| Hall Patricia | Chief Accounting Officer | 31 Okt. 2006 M | 13.514 | 0 | 0 | $0 |
| Ford R Lynch | Sr. VP Marketing and Sales | 26 Juli 2004 P | 4.300 | 0 | 0 | $0 |
| Craig D Wright | Chief Scientific Officer | 9 Maret 2004 A | 51.626 | 0 | 0 | $0 |
| Rachel K. King | Direktur | 20 Juni 2026 M | 44.070 | 0 | 0 | $0 |
| Gregg H Alton | Direktur | 20 Juni 2026 M | 47.685 | 0 | 0 | $0 |
| Richard J Rodgers | Direktur | 20 Juni 2026 M | 47.370 | 0 | 0 | $0 |
| David M Mott | Direktur | 20 Juni 2026 M | 79.770 | 0 | 0 | $0 |
| Margaret G Mcglynn | Direktur | 20 Juni 2026 M | 44.468 | 0 | 0 | $0 |
| DOUGLAS RICHARD | Direktur | 20 Juni 2026 M | 73.220 | 0 | 0 | $0 |
| John W. Shiver | Direktur | 18 Juni 2026 A | 7.947 | 0 | 0 | $0 |
| Charles W. Newton | Direktur | 18 Juni 2026 A | 9.520 | 0 | 0 | $0 |
| James F Young | Direktur | 31 Des. 2024 S | 51.760 | 0 | 0 | $0 |
| Michael A Mcmanus JR | Direktur | 16 Juni 2022 M | 10.101 | 0 | 0 | $0 |
| Gary C Evans | Direktur | 17 Juni 2021 M | 19.549 | 0 | 0 | $0 |
| Gail Boudreaux | Direktur | 16 Maret 2017 A | 200.000 | 0 | 0 | $0 |
| Rajiv I. Modi | Direktur | 17 Juni 2015 S | 2.500.000 | 0 | 0 | $0 |
| John O Marsh JR | Direktur | 6 Maret 2014 A | 36.000 | 0 | 0 | $0 |
| John A Lambert | Direktur | 15 April 2010 A | 80.000 | 0 | 0 | $0 |
| Thomas P Monath | Direktur | 5 Maret 2009 A | 3.225.366 | 0 | 0 | $0 |
| James B Tananbaum | Direktur | 5 Maret 2009 A | 3.151.818 | 0 | 0 | $0 |
| ODONNELL DENIS M | Direktur | 7 Maret 2007 A | 221.495 | 0 | 0 | $0 |
| KELLY MITCHELL J | Direktur | 3 Maret 2006 S | 500 | 0 | 0 | $0 |
| Michael J Lazarus MD | Direktur | 17 Feb. 2006 A | 11.927 | 0 | 0 | $0 |
| Susan B Bayh | Direktur | 4 Mei 2005 A | · | 0 | 0 | $0 |
| Ronlad H Walker | Direktur | 9 Maret 2004 A | · | 0 | 0 | $0 |
| KING PHARMACEUTICALS INC | Pemilik 10% | 16 Juli 2004 J | 4.100.931 | 0 | 0 | $0 |
| Raymond Joseph Hage | · | 2 Juli 2009 M | 5.251 | 0 | 0 | $0 |
| Nelson M Simms | · | 15 Agu 2005 D | 275.000 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 30 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| PBE · Invesco Exchange-Traded Fund Trust | 3,18% | 1.243.050 SH | 2 Okt. 2026 | Harian |
| IDNA · iShares Trust | 1,41% | 388.569 SH | 11 Sep. 2026 | Harian |
| BBP · ETFis Series Trust I | 1,14% | 152.832 NS | 31 Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,38% | 255.116 NS | 31 Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,12% | 11.718 SH | 2 Okt. 2026 | Harian |
| IBB · iShares Trust | 0,11% | 1.194.423 SH | 11 Sep. 2026 | Harian |
| PWS · Pacer Funds Trust | 0,11% | 3.486 NS | 31 Juli 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,09% | 132.629 SH | 19 Agu 2026 | Harian |
| IWM · iShares Trust | 0,05% | 3.915.893 SH | 11 Sep. 2026 | Harian |
| VBK · VANGUARD INDEX FUNDS | 0,04% | 2.187.922 SH | 19 Agu 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 877.397 SH | 19 Agu 2026 | Harian |
| RSSL · Global X Funds | 0,04% | 72.850 NS | 31 Juli 2026 | N-PORT |
| TECB · iShares Trust | 0,03% | 15.347 SH | 11 Sep. 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 1.892.748 SH | 19 Agu 2026 | Harian |
| VB · VANGUARD INDEX FUNDS | 0,02% | 3.775.808 SH | 19 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,02% | 416.565 SH | 19 Agu 2026 | Harian |
| ISCG · iShares Trust | 0,02% | 19.900 SH | 11 Sep. 2026 | Harian |
| PRF · Invesco Exchange-Traded Fund Trust | 0,02% | 159.261 SH | 2 Okt. 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 64.499 NS | 31 Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 8.992 SH | 11 Sep. 2026 | Harian |
| TILT · FlexShares Trust | 0,00% | 12.956 NS | 31 Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 248.773 SH | 11 Sep. 2026 | Harian |
| IWV · iShares Trust | 0,00% | 42.080 SH | 10 Sep. 2026 | Harian |
| DXUV · Dimensional ETF Trust | 0,00% | 228 NS | 31 Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 5.197.170 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 12.359 SH | 19 Agu 2026 | Harian |
| IWN · iShares Trust | · | 1.443.464 SH | 11 Sep. 2026 | Harian |
| ISCB · iShares Trust | · | 6.917 SH | 11 Sep. 2026 | Harian |
| ISCV · iShares Trust | · | 20.646 SH | 11 Sep. 2026 | Harian |
| SMLF · iShares Trust | · | 111.155 SH | 11 Sep. 2026 | Harian |
NVAX Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 15 analis
BELI
Target median
$16.02
+53,2%
4 26,7%
Beli Kuat
6 40,0%
Beli
2 13,3%
Tahan
2 13,3%
Jual
1 6,7%
Jual Kuat
Target Harga 12 Bulan
9 analis · 2026-10-03Target rata-rata $14.00 +33,9%
Sekarang
Harga saat ini $10.46
Rendah$7.00
Rata-rata$14.00
Tinggi$25.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | · |
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | · |
| SRPT | $2.26B | -3.0 | 15.6% | -32.5% | -57.1% | · |
| GENB | · | · | · | · | · | · |
| NTLA | $1.05B | -2.4 | 16.9% | -609.8% | -59.5% | · |
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | · |
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | · |
| XNCR | $1.10B | -12.3 | 13.7% | -73.2% | -14.0% | · |
| SNDX | $1.84B | -6.4 | 627.8% | -165.6% | -257.1% | · |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 6, 2026